Search Lavipharm.com

 

2019

 Peania, December 13th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to its Executive Chairman, Mr. Athanasios Lavidas,...

10.22.19 Announcement  Peania, October 22nd, 2019 - Following recent press posts referring to Mr. Telemaque Lavidas, a member of the Board of Directors of Lavipharm SA, regarding a case being investigated by the US Authorities, Lavipharm S.A. informs that the case has no relation to the...

 Peania, November 29th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Mr. Athanasios...

Peania, November 13th2019 Η Lavipharm S.A. announces that as of today, November 13th 2019, Mr. Panagiotis Giannouleas, an experienced executive in the pharmaceutical market, assumes the responsibilities of Chief Operating Officer (COO) and Country Manager. ...

Lavipharm S.A. announces that, as of September 6th  2019, Mr. Antonis Vogiatzis, who held the position of General Manager, is no longer with the company....